Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-03-28

FDA Approved: DIPROLENE — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for Diprolene (betamethasone dipropionate) from Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIPROLENE (Betamethasone dipropionate)

Snippet

SUPPL AP for DIPROLENE (BETAMETHASONE DIPROPIONATE)